AMPH
AMPH
NASDAQ · Pharmaceuticals

Amphastar Pharmaceuticals In

$28.02
+0.90 (+3.32%)
As of Nov 7, 1:51 AM ET ·
Analyst Consensus
Sell
12
Analysts
Moderate
Coverage
Buy 0 0%
Hold 8 67%
Sell 4 33%
Price Target
Analyst Price Target +131.0% upside
Low Target $41.78
Average Target $64.73
High Target $94.19
Current Price $28.02
Current
$28.02
Target
$64.73
$41.78 $64.73 avg $94.19
Scenario Analysis
Bear Case
$41.78
49.1%
Low target
Base Case
$64.73
+131.0%
Avg target
Bull Case
$94.19
+236.2%
High target
Risk/Reward
4.8x
Highly favorable
Price in Context
52-Week High
$29.52
-5.1% from high
52-Week Low
$16.65
+68.3% from low
Target vs 52W High
$64.73
+119.3% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $0.88
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%